Fertility Clinics Are Built Around Women. Half of Infertility Cases Involve Men.

Since this outlet's recent coverage of automation displacing factory workers, a quieter crisis has been building in a different corner of healthcare: the systematic under-diagnosis of male infertility, with real costs for couples navigating an already punishing process.

The Numbers Are Not in Dispute

Infertility affects roughly one in six couples globally, according to BBC News. Male factors—either alone or combined with female causes—account for approximately half of those cases. That is not a fringe statistic. It comes from established clinical data cited by the U.K.'s National Institute for Health and Care Excellence (NICE).

NICE guidelines are explicit: couples who have been trying to conceive for 12 months without success should be assessed together, men and women in parallel. The standard is clear. The practice, according to clinicians and patients, often is not.

What Patients Actually Experience

Luke, a U.K. patient whose last name was not published by BBC News, began trying to start a family with his wife in mid-2020. After 18 months without success, the couple was referred for testing. What followed was more than a year in which, he says, every appointment was in his wife's name. When he completed paperwork, clinics contacted his wife even though his contact details were on file.

It took a failed round of IVF before anyone told him there might be an issue with his sperm.

"There were things on my side that could have been looked into much sooner, rather than treating me as an accessory to the process," he told BBC News.

IVF is physically demanding and expensive. According to BBC News, delayed male diagnosis means couples may face a tougher, more expensive path through fertility care—potentially exhausting resources before the actual problem is identified.

A System-Level Problem, Not Just Attitude

Prof. Bola Grace of University College London has studied this directly. Her 2019 research found that many men wanted greater involvement in fertility care but felt their input was not heard or sought. Her conclusion is structural, not simply cultural: fertility services that exclude men produce men who disengage, which then gets misread as men not caring.

"We've created a cycle where men are excluded, but then they're also blamed for not showing up," Grace told BBC News.

The downstream effect falls heavily on women. Grace notes that when male involvement is minimal, women absorb a disproportionate share of the coping, planning, worrying, and decision-making. That is not a feminist talking point. It is a systems-efficiency problem. One undertested partner means worse diagnostic accuracy for the whole couple.

The Strongest Counter-Argument

Some clinicians would argue that the female-first orientation of fertility care is not arbitrary bias but a reflection of clinical reality: female reproductive assessment involves more variables, more time-sensitive tests (ovarian reserve, hormone cycling), and more treatment options that need to be sequenced carefully. From that view, prioritizing the female workup first is a rational allocation of limited clinical resources, not neglect of men.

That argument has some merit. Allan Pacey, professor of andrology at the University of Manchester and a former chair of the British Fertility Society, acknowledges that fertility units are typically led by gynaecologists whose training focuses on female reproductive health, which has shaped how fertility care developed since the first IVF birth in 1978. But the argument breaks down when, as in Luke's case, male factors go unexamined for over a year while a couple undergoes invasive treatment. Running a semen analysis—a non-invasive test—in parallel with early female screening can redirect an entire treatment plan. NICE already recommends this. The gap is in implementation.

A Policy Gap That Reinforces the Problem

At a policy level, Pacey points to a telling imbalance: the Department of Health's recently published health strategies for England mention fertility around 20 times in the women's version, with a page devoted to support and clinical guidance, while the men's document mentions it just five times—mostly in relation to obesity, alcohol, or other health issues. Pacey calls this a "missed opportunity to level the playing field."

A Department of Health and Social Care spokesperson said: "It is right that men receive the same level of support, information and care as women when navigating fertility problems," adding that it will continue working with NHS England to ensure men's fertility is "properly reflected in how services are designed and delivered."

What Needs to Happen

Grace's research points toward a specific reform: integrate men into fertility care from the first appointment, not as a secondary concern but as a co-patient. That means appointments structured for two, paperwork filed for both, and parallel testing as a default rather than an exception.

NICE has already written this into guidelines. The question Grace and her colleagues have not yet fully answered, and which no source in this reporting resolves, is why implementation remains so inconsistent years after those guidelines were published and whether NHS funding structures, clinic staffing models, or something else is driving the gap.